Patents by Inventor Guenter Stalla

Guenter Stalla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-terminal HSP90 inhibitors to treat pituitary adenomas
    Patent number: 9877947
    Abstract: The present invention relates to C-terminal HSP90 inhibitors, like silibinin, novobiocin and derivatives thereof, stereoisomeric forms, prodrugs, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said compounds and its compositions have been identified as useful for the treatment of pituitary adenomas such as corticotroph adenomas, lactotroph adenomas, somatotroph adenomas and thyrotroph adenomas.
    Type: Grant
    Filed: January 4, 2014
    Date of Patent: January 30, 2018
    Assignee: Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V.
    Inventors: Marcelo Paez-Pereda, Guenter Stalla
  • C-TERMINAL HSP90 INHIBITORS TO TREAT PITUITARY ADENOMAS
    Publication number: 20150335613
    Abstract: The present invention relates to C-terminal HSP90 inhibitors, like silibinin, novobiocin and derivatives thereof, stereoisomeric forms, prodrugs, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said compounds and its compositions have been identified as useful for the treatment of pituitary adenomas such as corticotroph adenomas, lactotroph adenomas, somatotroph adenomas and thyrotroph adenomas.
    Type: Application
    Filed: January 4, 2014
    Publication date: November 26, 2015
    Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Marcelo Paez-Pereda, Guenter Stalla